Collaborative Stage for TNM 7 - Revised 11/04/2009 [ Schema ]
CS Site-Specific Factor 3
International Prognostic Index (IPI)
- Note 1: The IPI has been developed for lymphomas and predicts outcome based on the following adverse factors:
Age more than 60 years
Stage III or IV
Number of extranodal sites involved more than 1
Patient's performance status (ECOG) more than 2
Serum LDH level abnormal
- Note 2: Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available.
- Note 3: There are now three indices/score associated with Lymphoma: The International Prognostic Index (IPI, SSF3): the Folliucular Lymphoma International Prognostic Index (FLIPI, SSF4) and the International Prognostic Score (for Hodgkin lymphomas, SSF5.) Physicians may use these indices/scores interchangeably. If the point value and the index/score is documented, code the appropriate SSF and the other two SSF's as 999. If a point value of 5 or less is documented, but there is no documentation for which index/score was used, code 999 for all three SSF's. If the point value is 6 or 7, code SSF5 (IPS).
|990||Stated as low risk (0-1 points)|
|991||Stated as low intermediate risk (2 points)|
|992||Stated as intermediate risk (3 points)|
|993||Stated as high risk (4-5 points)|
Not documented in patient record